148 related articles for article (PubMed ID: 19225206)
1. Qualitative and quantitative changes in coronary plaque associated with atorvastatin therapy.
Hirayama A; Saito S; Ueda Y; Takayama T; Honye J; Komatsu S; Yamaguchi O; Li Y; Yajima J; Nanto S; Takazawa K; Kodama K
Circ J; 2009 Apr; 73(4):718-25. PubMed ID: 19225206
[TBL] [Abstract][Full Text] [Related]
2. Plaque stabilization by intensive LDL-cholesterol lowering therapy with atorvastatin is delayed in type 2 diabetic patients with coronary artery disease-Serial angioscopic and intravascular ultrasound analysis.
Takayama T; Hiro T; Ueda Y; Honye J; Komatsu S; Yamaguchi O; Li Y; Yajima J; Takazawa K; Nanto S; Saito S; Hirayama A; Kodama K
J Cardiol; 2013 Jun; 61(6):381-6. PubMed ID: 23478121
[TBL] [Abstract][Full Text] [Related]
3. Statin-induced structural changes in coronary plaques evaluated by intracoronary imaging.
Komiyama N
Circ J; 2009 Apr; 73(4):628-9. PubMed ID: 19318726
[No Abstract] [Full Text] [Related]
4. Plaque-stabilizing effect of atorvastatin is stronger for plaques evaluated as more unstable by angioscopy and intravenous ultrasound.
Hirayama A; Saito S; Ueda Y; Takayama T; Honye J; Komatsu S; Yamaguchi O; Li Y; Yajima J; Nanto S; Takazawa K; Kodama K
Circ J; 2011; 75(6):1448-54. PubMed ID: 21502706
[TBL] [Abstract][Full Text] [Related]
5. Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: serial evaluation by coronary angioscopy.
Takano M; Mizuno K; Yokoyama S; Seimiya K; Ishibashi F; Okamatsu K; Uemura R
J Am Coll Cardiol; 2003 Aug; 42(4):680-6. PubMed ID: 12932601
[TBL] [Abstract][Full Text] [Related]
6. Influence of achieved low-density lipoprotein cholesterol level with atorvastatin therapy on stabilization of coronary plaques: sub-analysis of the TWINS study.
Okada K; Ueda Y; Takayama T; Honye J; Komatsu S; Yamaguchi O; Li Y; Yajima J; Takazawa K; Nanto S; Saito S; Hirayama A; Kodama K
Circ J; 2012; 76(5):1197-202. PubMed ID: 22343194
[TBL] [Abstract][Full Text] [Related]
7. Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.
Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
J Am Coll Cardiol; 2015 Aug; 66(5):495-507. PubMed ID: 26227186
[TBL] [Abstract][Full Text] [Related]
8. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
Nissen SE; Tuzcu EM; Schoenhagen P; Brown BG; Ganz P; Vogel RA; Crowe T; Howard G; Cooper CJ; Brodie B; Grines CL; DeMaria AN;
JAMA; 2004 Mar; 291(9):1071-80. PubMed ID: 14996776
[TBL] [Abstract][Full Text] [Related]
9. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study).
Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
J Am Coll Cardiol; 2009 Jul; 54(4):293-302. PubMed ID: 19608026
[TBL] [Abstract][Full Text] [Related]
10. Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis.
Hong YJ; Jeong MH; Hachinohe D; Ahmed K; Choi YH; Cho SH; Hwang SH; Ko JS; Lee MG; Park KH; Sim DS; Yoon NS; Yoon HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
Circ J; 2011; 75(2):398-406. PubMed ID: 21157106
[TBL] [Abstract][Full Text] [Related]
11. Rationale and design of a randomized clinical study to investigate the effect of ezetimibe, a cholesterol absorption inhibitor, on the regression of intracoronary plaque evaluated by non-obstructive angioscopy and ultrasound: The ZIPANGU study.
Hiro T; Hirayama A; Ueda Y; Komatsu S; Matsuoka H; Takayama T; Ishihara M; Hayashi T; Saito S; Kodama K;
J Cardiol; 2014 Dec; 64(6):501-7. PubMed ID: 24725763
[TBL] [Abstract][Full Text] [Related]
12. Virtual histology findings and effects of varying doses of atorvastatin on coronary plaque volume and composition in statin-naive patients: the VENUS study.
Lee SW; Hau WK; Kong SL; Chan KK; Chan PH; Lam SC; Tam FC; Wong MK; Chan CW; Lam YM; Tse HF; Chan RH
Circ J; 2012; 76(11):2662-72. PubMed ID: 22864277
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Effect of Rosuvastatin 2.5 mg vs 20 mg on Coronary Plaque Determined by Angioscopy and Intravascular Ultrasound in Japanese With Stable Angina Pectoris (from the Aggressive Lipid-Lowering Treatment Approach Using Intensive Rosuvastatin for Vulnerable Coronary Artery Plaque [ALTAIR] Randomized Trial).
Takayama T; Komatsu S; Ueda Y; Fukushima S; Hiro T; Hirayama A; Saito S;
Am J Cardiol; 2016 Apr; 117(8):1206-12. PubMed ID: 26879069
[TBL] [Abstract][Full Text] [Related]
14. Effect of intensive atorvastatin therapy on coronary atherosclerosis progression, composition, arterial remodeling, and microvascular function.
Eshtehardi P; McDaniel MC; Dhawan SS; Binongo JN; Krishnan SK; Golub L; Corban MT; Raggi P; Quyyumi AA; Samady H
J Invasive Cardiol; 2012 Oct; 24(10):522-9. PubMed ID: 23043036
[TBL] [Abstract][Full Text] [Related]
15. Assessment of plaque vulnerability by angioscopic classification of plaque color.
Ueda Y; Ohtani T; Shimizu M; Hirayama A; Kodama K
Am Heart J; 2004 Aug; 148(2):333-5. PubMed ID: 15309005
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of statin therapy on coronary atherosclerosis following an acute coronary syndrome.
Rodés-Cabau J; Tardif JC; Cossette M; Bertrand OF; Ibrahim R; Larose E; Grégoire J; L'allier PL; Guertin MC
Am J Cardiol; 2009 Sep; 104(6):750-7. PubMed ID: 19733706
[TBL] [Abstract][Full Text] [Related]
17. Stabilization and regression of coronary plaques treated with pitavastatin proven by angioscopy and intravascular ultrasound--the TOGETHAR trial.
Kodama K; Komatsu S; Ueda Y; Takayama T; Yajima J; Nanto S; Matsuoka H; Saito S; Hirayama A
Circ J; 2010 Sep; 74(9):1922-8. PubMed ID: 20625215
[TBL] [Abstract][Full Text] [Related]
18. Ex vivo comparison of angioscopy and histopathology for the evaluation of coronary plaque characteristics.
Shibuya M; Fujii K; Hao H; Imanaka T; Fukunaga M; Miki K; Tamaru H; Nakata T; Sawada H; Naito Y; Hirota S; Masuyama T
Int J Cardiovasc Imaging; 2016 Jun; 32(6):863-9. PubMed ID: 26873010
[TBL] [Abstract][Full Text] [Related]
19. Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT study.
Komukai K; Kubo T; Kitabata H; Matsuo Y; Ozaki Y; Takarada S; Okumoto Y; Shiono Y; Orii M; Shimamura K; Ueno S; Yamano T; Tanimoto T; Ino Y; Yamaguchi T; Kumiko H; Tanaka A; Imanishi T; Akagi H; Akasaka T
J Am Coll Cardiol; 2014 Dec; 64(21):2207-17. PubMed ID: 25456755
[TBL] [Abstract][Full Text] [Related]
20. Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSound (PRECISE-IVUS Trial): Study protocol for a randomized controlled trial.
Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Ono T; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
J Cardiol; 2015 Oct; 66(4):353-8. PubMed ID: 25577723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
